LIG Biowise's CEO Alex Sheppard wins BioNow's BioCap 2018 Pitch Competition

LIG Biowise
October 1, 2018

We are delighted to announce that last week our CEO Alex Sheppard beat 5 other companies in a pitching competition in front of a panel over 60 representatives from the international life science investment community.

Read More

LIG Biowise Raises £1.8m in Series A Funding

LIG Biowise
February 5, 2018

LIG Biowise raises £1.8m in Series A fundraising Financing the development of a versatile point-of-care diagnostic kit for infectious disease Initially targeting upper respiratory tract infections 

Read More

LIG Biowise present the state of antimicrobial resistance at BioInfect 2017

LIG Biowise
January 25, 2018

This week, we had the privilege of attending and contributing to Bionow's BioInfect 2017 conference - a one day event looking at the critical issues relating to the development of new anti-infectives..

Read More

LIG Biowise Announces Collaboration with Protein Technologies and Lucid Innovation

Steve Wright
October 9, 2017

Manchester Science Park (MSP) today announced their partnership with science park customer Protein Technologies to launch BioSpace, an initiative to provide laboratory space to early-stage Biotech and Medtech companies, as well as entrepreneurial scientists. MSP have called the BiOSpace an "unrestricted, pay-as-you-go access to state-of-the-art facilities and multi-million pound equipment."

Read More